NL 792 100 mg Pill - brown & yellow capsule/oblong, 19mm
Pill with imprint NL 792 100 mg is Brown & Yellow, Capsule/Oblong and has been identified as Doxycycline Monohydrate 100 mg. It is supplied by Novel Laboratories, Inc.
Doxycycline is used in the treatment of Actinomycosis; Acne; Amebiasis; Anthrax; Gonococcal Infection, Uncomplicated and belongs to the drug classes miscellaneous antimalarials, tetracyclines. There is positive evidence of human fetal risk during pregnancy. Doxycycline 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NL 792 100 mg
Doxycycline Monohydrate
- Imprint
- NL 792 100 mg
- Strength
- 100 mg
- Color
- Brown & Yellow
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Miscellaneous antimalarials, Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novel Laboratories, Inc.
- National Drug Code (NDC)
- 40032-0792
- Inactive Ingredients
-
silicon dioxide,
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
FD&C Red No. 3,
D&C Yellow No. 10,
titanium dioxide,
gelatin,
sodium lauryl sulfate,
shellac,
potassium hydroxide
Note: Inactive ingredients may vary.
Related images for "NL 792 100 mg"
More about doxycycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,642)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous antimalarials
- Breastfeeding
- En español
Patient resources
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +8 more
Professional resources
- Doxycycline monograph
- Doxycycline (Topical) (AHFS Monograph)
- Doxycycline Hyclate (EENT) (AHFS Monograph)
- Doxycycline (FDA)
- Doxycycline Delayed Release Capsule (FDA)
Other brands
Vibramycin, Monodox, Doryx, Oracea, ... +7 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.